Thierry Andre Michel Louat

Title: Innovations of Thierry Andre Michel Louat

Introduction

Thierry Andre Michel Louat is a notable inventor based in Saint-Chamond, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of immunosuppressive agents. With a total of 2 patents, his work focuses on innovative compounds that address critical medical needs.

Latest Patents

Louat's latest patents include the development of Thiazolopyrimidine modulators as immunosuppressive agents. These inventions relate to compounds of specific formulas and their pharmaceutical acceptable addition salts, stereoisomers, or solvates. The compounds are designed to serve as biologically active ingredients, particularly as medicaments for treating immune and auto-immune disorders, as well as organ and cell transplant rejections. The detailed methodology for their preparation and pharmaceutical compositions is also covered in his patents.

Career Highlights

Louat is affiliated with Katholieke Universiteit Leuven, also known as KU Leuven R&D. His work at this prestigious research institution has allowed him to explore and develop innovative solutions in the pharmaceutical sector. His contributions have been instrumental in advancing medical treatments and improving patient outcomes.

Collaborations

Throughout his career, Louat has collaborated with esteemed colleagues such as Piet Herdewijn and Steven De Jonghe. These partnerships have fostered a collaborative environment that enhances research and innovation in the field.

Conclusion

Thierry Andre Michel Louat's contributions to the field of immunosuppressive agents highlight his role as a significant inventor in the pharmaceutical industry. His innovative work continues to pave the way for advancements in medical treatments.